Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial

Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-08T13:56:32.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1, indicating a minor version update in the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-15T02:35:42.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-07T21:19:41.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Minor UI and editorial text updates were made: a 'Show glossary' option was added; capitalization changes were applied to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag was updated to v3.4.0 replacing the prior v3.3.4 and lowercase variants. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-24T12:01:06.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.3.3 to v3.3.4, replacing the previous revision tag. This does not alter the study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-01-17T07:16:29.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Location information has been reorganized under a single 'Locations' section, listing Florida, Georgia, and New Jersey, with previous separate location headings removed. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.5%
    Check dated 2025-12-18T23:12:16.000Z thumbnail image

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.